Markus Knuf

6.4k total citations · 1 hit paper
139 papers, 3.9k citations indexed

About

Markus Knuf is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, Markus Knuf has authored 139 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Epidemiology, 50 papers in Microbiology and 28 papers in Infectious Diseases. Recurrent topics in Markus Knuf's work include Pneumonia and Respiratory Infections (56 papers), Bacterial Infections and Vaccines (50 papers) and Influenza Virus Research Studies (38 papers). Markus Knuf is often cited by papers focused on Pneumonia and Respiratory Infections (56 papers), Bacterial Infections and Vaccines (50 papers) and Influenza Virus Research Studies (38 papers). Markus Knuf collaborates with scholars based in Germany, Belgium and United States. Markus Knuf's co-authors include Fred Zepp, Ralf Clemens, B. Ruf, Peter Wutzler, Heinz‐Josef Schmitt, Pirmin Habermehl, Timo Vesikari, Theodore F. Tsai, Lode Schuerman and Dorothee Kieninger‐Baum and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Markus Knuf

133 papers receiving 3.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants

2023 175 citations Simon B. Drysdale, Katrina Cathie et al. New England Journal of Medicine profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Markus Knuf	3.0k	1.3k	759	494	382	139	3.9k
David P. Greenberg	3.3k 1.1×	1.5k 1.1×	953 1.3×	426 0.9×	752 2.0×	98	4.4k
David W. Scheifele	4.0k 1.3×	2.1k 1.6×	1.1k 1.5×	569 1.2×	726 1.9×	239	5.6k
Johannes G. Liese	2.5k 0.8×	996 0.8×	811 1.1×	947 1.9×	322 0.8×	133	4.3k
Fiona van der Klis	2.8k 1.0×	891 0.7×	1.5k 2.0×	948 1.9×	706 1.8×	175	5.4k
Mark M. Blatter	3.1k 1.0×	925 0.7×	540 0.7×	489 1.0×	343 0.9×	84	4.2k
Javier Díez‐Domingo	3.6k 1.2×	737 0.6×	919 1.2×	334 0.7×	540 1.4×	220	4.7k
James C. King	3.2k 1.1×	465 0.4×	1.0k 1.3×	566 1.1×	468 1.2×	73	3.8k
Stan L. Block	4.0k 1.3×	990 0.8×	793 1.0×	569 1.2×	523 1.4×	128	5.1k
Matthew D. Snape	2.7k 0.9×	2.0k 1.5×	539 0.7×	426 0.9×	286 0.7×	128	3.7k
Guy A. M. Berbers	4.2k 1.4×	2.7k 2.1×	1.3k 1.7×	1.0k 2.1×	661 1.7×	204	6.6k

Countries citing papers authored by Markus Knuf

Since Specialization

Citations

This map shows the geographic impact of Markus Knuf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Knuf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Knuf more than expected).

Fields of papers citing papers by Markus Knuf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Knuf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Knuf. The network helps show where Markus Knuf may publish in the future.

Co-authorship network of co-authors of Markus Knuf

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Knuf. A scholar is included among the top collaborators of Markus Knuf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Knuf. Markus Knuf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Meyer, Anna C., et al.. (2025). P-631. RSV Prophylaxis with Nirsevimab in Infants: Systematic Review of Early Real-World Evidence on Effectiveness and Impact. Open Forum Infectious Diseases. 12(Supplement_1). 1 indexed citations

Knuf, Markus, et al.. (2024). Antibody persistence and revaccination recommendations of MenACWY-TT: a review of clinical studies assessing antibody persistence up to 10 years after vaccination. Expert Review of Vaccines. 23(1). 614–635. 2 indexed citations

Knuf, Markus, et al.. (2023). Penta- and hexavalent vaccination of extremely and very-to-moderate preterm infants born at less than 34 weeks and/or under 1500 g: A systematic literature review. Human Vaccines & Immunotherapeutics. 19(1). 2191575–2191575. 2 indexed citations

Drysdale, Simon B., Katrina Cathie, Florence Flamein, et al.. (2023). Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants. New England Journal of Medicine. 389(26). 2425–2435. 175 indexed citations breakdown →

Witte, Julian, et al.. (2022). Epidemiology and economic burden of meningococcal disease in Germany: A systematic review. Vaccine. 40(13). 1932–1947. 11 indexed citations

Papan, Cihan, Alberto Argentiero, Ortwin Adams, et al.. (2022). Association of viral load with TRAIL, IP‐10, CRP biomarker signature and disease severity in children with respiratory tract infection or fever without source: A prospective, multicentre cohort study. Journal of Medical Virology. 95(1). e28113–e28113. 11 indexed citations

Mukherjee, Piyali, et al.. (2021). Hexavalent vaccines in infants: a systematic literature review and meta-analysis of the solicited local and systemic adverse reactions of two hexavalent vaccines. Expert Review of Vaccines. 20(3). 319–330. 6 indexed citations

Serra, Lidia, et al.. (2021). Review of clinical studies comparing meningococcal serogroup C immune responses induced by MenACWY-TT and monovalent serogroup C vaccines. Human Vaccines & Immunotherapeutics. 17(7). 2205–2215. 10 indexed citations

Knuf, Markus, et al.. (2021). Hexavalent vaccines: What can we learn from head-to-head studies?. Vaccine. 39(41). 6025–6036. 9 indexed citations

10.

Martinón‐Torres, Federico, Muhamed‐Kheir Taha, Markus Knuf, et al.. (2021). Evolving strategies for meningococcal vaccination in Europe: Overview and key determinants for current and future considerations. Pathogens and Global Health. 116(2). 85–98. 29 indexed citations

11.

Huppertz, Hans‐Iko, Reinhard Berner, Renate Schepker, et al.. (2020). Verwendung von Masken bei Kindern zur Verhinderung der Infektion mit SARS-CoV-2. Monatsschrift Kinderheilkunde. 169(1). 52–56. 10 indexed citations

12.

Esposito, Susanna, Paola Stefanelli, Norman K. Fry, et al.. (2019). Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines. Frontiers in Immunology. 10. 1344–1344. 126 indexed citations

13.

Knuf, Markus, Geert Leroux‐Roels, H. C. Rümke, et al.. (2015). Immunogenicity and safety of cell-derived MF59®-adjuvanted A/H1N1 influenza vaccine for children. Human Vaccines & Immunotherapeutics. 11(2). 358–376. 11 indexed citations

14.

Kowalzik, Frank, Fred Zepp, Isabell Hoffmann, et al.. (2015). Disease Burden of Rotavirus Gastroenteritis in Children Residing in Germany. The Pediatric Infectious Disease Journal. 35(1). 97–103. 8 indexed citations

15.

Damm, Oliver, Martin Eichner, Markus A. Rose, et al.. (2014). Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany. The European Journal of Health Economics. 16(5). 471–488. 29 indexed citations

16.

Esposito, Susanna, Robert Cohen, Javier Díez‐Domingo, et al.. (2012). Do We Know When, What and For How Long to Treat?. The Pediatric Infectious Disease Journal. 31(6). e78–e85. 87 indexed citations

17.

Gillard, Paul, Adrian Caplanusi, Markus Knuf, et al.. (2012). An assessment of prime‐boost vaccination schedules with AS03_A‐adjuvanted prepandemic H5N1 vaccines: a randomized study in European adults. Influenza and Other Respiratory Viruses. 7(1). 55–65. 28 indexed citations

18.

Kampmann, Christoph, et al.. (2010). Mid-term results of a modified arterial switch operation using the direct reconstruction technique of the pulmonary artery.. PubMed. 17(6). 574–9. 2 indexed citations

19.

Knuf, Markus, Joanne Wolter, Lode Schuerman, et al.. (2007). Neonatal Vaccination with an Acellular Pertussis Vaccine Accelerates the Acquisition of Pertussis Antibodies in Infants. The Journal of Pediatrics. 152(5). 655–660.e1. 101 indexed citations

20.

Kamin, Wolfgang, et al.. (2006). Anaphylaxie nach gleichzeitiger Impfung gegen Masern, Mumps, Röteln und Frühsommer-Meningoenzephalitis aufgrund einer Gelatineallergie. Klinische Pädiatrie. 218(2). 92–94. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact